title: Concept of a point of care test to detect new oral anticoagulants in urine samples.
abstract: New oral anticoagulants (NOAC) are approved for several indications for prophylaxis and treatment of venous thromboembolism and for prevention of embolism in atrial fibrillation at fixed daily doses without need of laboratory guided dose adjustment. Due to their low molecular weight of about 500 to 600 Dalton and their hydrophilicity free anticoagulant is excreted immediately through glomerular filtration into the urine. Impairment of renal function may increase the plasma concentration of the anticoagulants and lowered creatinine clearance is a declared contraindication. In contrast to the initial aim of development the anticoagulant effect is required to be determined in special clinical situations. Several specific and non-specific assays using plasma samples are currently undergoing standardization. As all NOACs are excreted into the urine, specific assays were developed for this matrix to determine them quantitatively of qualitatively. Urine samples can be easily and repetitively obtained avoiding problems and risks associated with blood sampling. The qualitative assay can be performed as a point of care test (POC) also by the patient by judging the different colours for the absence or presence of the drugs with the naked eye. The test is rapid (results available within 15 min), sensitive, specific and accurate and does not require a purified NOAC as control. The tests may be a tool for clinicians who need to know for treatment decisions if a NOAC is on board or not. As the tests are specific for oral direct thrombin inhibitors and for oral direct factor Xa inhibitors, the indication does not interfere with other qualitative POC test in development using clotting systems. The test may be indicated for patients at acute hospitalization, before surgery or central nervous system puncture anaesthesia, if fibrinolytic therapy is indicated, acute deterioration of renal function, and for control of adherence to therapy.
authors.affiliation: Clinical Pharmacology, Medical Faculty of Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany. job.harenberg@medmam.uni-heidelberg.de.
authors.forename: Job
authors.initials: J
authors.lastname: Harenberg
authors.forename: Sandra
authors.initials: S
authors.lastname: Krämer
authors.forename: Shanshan
authors.initials: S
authors.lastname: Du
authors.forename: Christel
authors.initials: C
authors.lastname: Weiss
authors.forename: Roland
authors.initials: R
authors.lastname: Krämer
references.citation: Clin Chim Acta. 2009 Aug;406(1-2):81-5
references.pmid: 19477170
references.citation: J Chromatogr. 1985 Mar 22;338(2):325-34
references.pmid: 3998021
references.citation: J Clin Pathol. 2012 Nov;65(11):1031-5
references.pmid: 22859395
references.citation: Biomed Res Int. 2013;2013:213109
references.pmid: 23509691
references.citation: Semin Thromb Hemost. 1997;23(1):39-43
references.pmid: 9156409
references.citation: Thromb Res. 1983 Oct 1;32(1):1-13
references.pmid: 6658706
references.citation: Pathology. 2011 Dec;43(7):682-92
references.pmid: 22081129
references.citation: Chest. 2008 Jun;133(6 Suppl):160S-198S
references.pmid: 18574265
references.citation: J Emerg Med. 2012 Jun;42(6):682-91
references.pmid: 21911284
references.citation: Lancet. 2012 Jan 28;379(9813):322-34
references.pmid: 22137798
references.citation: Thromb Res. 2012 Apr;129 Suppl 1:S106-13
references.pmid: 22682119
references.citation: Chest. 2012 Feb;141(2 Suppl):e278S-e325S
references.pmid: 22315265
references.citation: Semin Thromb Hemost. 2013 Feb;39(1):66-71
references.pmid: 23271455
references.citation: J Eval Clin Pract. 2010 Jun;16(3):574-9
references.pmid: 20210821
references.citation: Am J Med. 2010 Jul;123(7):638-645.e4
references.pmid: 20609686
references.citation: Br J Clin Pharmacol. 2010 Nov;70(5):703-12
references.pmid: 21039764
references.citation: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD003839
references.pmid: 20393937
references.citation: Semin Thromb Hemost. 1997;23(1):31-7
references.pmid: 9156408
references.citation: Chem Commun (Camb). 2010 Mar 14;46(10):1667-9
references.pmid: 20177610
references.citation: Chest. 2012 Feb;141(2 Suppl):e495S-e530S
references.pmid: 22315270
references.citation: Thromb Haemost. 2010 Dec;104(6):1106-15
references.pmid: 20967400
references.citation: Clin Chem Lab Med. 2011 May;49(5):755-7
references.pmid: 21275811